- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Alimera Sciences Inc+ Add to Watchlist
ALIM:US6.6300 USD 0.3300 4.74%
As of 20:10:00 ET on 03/07/2014.
Company Profile for Alimera Sciences Inc (ALIM)
Alimera Sciences Inc. is a biopharmaceutical company. The Company researches, develops and commercializes prescription ophthalmic pharmaceuticals. Alimera Sciences is focused on diseases affecting the lining in the back of the eye, or retina.
Alimera Sciences Inc
Key Executives for Alimera Sciences Inc (ALIM)
|Philip R Tracy "Phil"Chairman||C Daniel Myers "Dan"President/CEO/Co-Founder|
|Richard S Eiswirth Jr "Rick"CFO/COO/Secretary||Kenneth Green "Ken"Senior VP/Chief Scientific Ofcr|
|David Holland "Dave"Senior VP:Sales & Marketing||Susan CaballaSenior VP:Regulatory Affairs|